Iguana Healthcare Management’s AbbVie ABBV Stock Holding History

Iguana Healthcare Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-50,000	Closed	-$4.84M	–	63
2017 Q4	$4.84M	Sell	50,000 -15,000	-23%	-$1.41M	3.15%	9
2017 Q3	$5.78M	Buy	65,000 +25,000	+63%	+$1.9M	3.15%	7
2017 Q2	$2.9M	Buy	+40,000	New	+$2.69M	1.64%	25
2015 Q2	–	Sell	-50,000	Closed	-$2.32M	–	70
2015 Q1	$2.32M	Sell	50,000 -25,000	-33%	-$1.51M	0.97%	36
2014 Q4	$4.91M	Sell	75,000 -50,000	-40%	-$3.15M	2.37%	11
2014 Q3	$7.22M	Buy	125,000 +40,000	+47%	+$2.22M	3.86%	5
2014 Q2	$4.8M	Buy	+85,000	New	+$4.46M	2.24%	11

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Iguana Healthcare Management's ABBV Position: Q1 2018 in Review

Iguana Healthcare Management sold out of AbbVie (ABBV) in Q1 2018, closing a stake of 50,000 shares — an estimated $4.84M sold.

Iguana Healthcare Management first reported a position in ABBV in Q2 2014 and held it in 7 quarters. The position peaked at $7.22M in Q3 2014. 2,016 funds tracked by Wall St. Rank hold ABBV as of Q1 2018.

Iguana Healthcare Management reported no remaining AbbVie position as of Q1 2018 after selling out during the quarter.
Iguana Healthcare Management sold 50,000 AbbVie shares in Q1 2018, an estimated $4.84M.
Iguana Healthcare Management first reported a position in AbbVie in Q2 2014 and held it in 7 quarters.
Iguana Healthcare Management's AbbVie position peaked at $7.22M in Q3 2014.
2,016 funds tracked by Wall St. Rank held AbbVie as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.